KHSRP mainly enhances tumor cell migration and invasion by promoting the maturation of miR-130b, miR-21 and miR-301a and by indirectly inhibiting the expression of their targets, such as endogenous EMT inhibitors BMP6, PDCD4 and TIMP3. Here, BMP6 is linked to neoplasm.